Its official: Suven Pharma and Cohance Lifesciences merger to take effect from May 1

Suven Pharmaceuticals and Cohance Lifesciences will merge on May 1, 2025, creating a diversified CDMO platform. The combined entity will offer end-to-end solutions to global pharmaceutical companies and aims to generate a revenue of Rs 6000 crore by FY29. The merger is part of Advent International’s plan to expand in the API and CDMO market, […]